Funding Rounds
Precirix Series B (2022, $87M)
PrecirixManufacturer of radio-immunotherapeutic drugs for cancer patients.
Summary
Stage: Series B
Raised Amount: $87.95M
Raised Date: 2022-01-01
Stage: Series B
Raised Amount: $87.95M
Raised Date: 2022-01-01
